Clinically shown to significantly improve the appearance of unwanted discoloration, age spots, sun spots and uneven skin tone, Lumixyl is a non-toxic, non-irritating, synthetic peptide technology. Lumixyl's ground-breaking Decapeptide-12 is the only peptide shown to measurably aid the skin in restraining tyrosinase, the enzyme responsible for initiating the overproduction of melanin, that can cause uneven pigmentation and dark spots.
Studies show that Decapeptide-12 helps inhibit the production of melanin more efficaciously than Hydroquinone - reducing melanin synthesis by as much as 40 percent compared to treatments with Hydroquinone, which reduced production by only 7 percent in the same study.
Lumixyl is an entirely new approach to naturally brighter, more vibrant skin, representing a new standard in physician-grade skin care. An innovation in skin brightening technology, the five products that comprise the Lumixyl Topical Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence.